Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2025-01-22 DOI:10.1111/bju.16641

Juho Pylväläinen, Kirsi Talala, Jani Raitanen, Antti Rannikko, Anssi Auvinen

引用次数: 0

Abstract

To assess the association between prostate-specific antigen (PSA) density (PSAD) and prostate cancer mortality after a benign result on systematic transrectal ultrasonography (TRUS)-guided prostate biopsy.

查看原文本刊更多论文

前列腺特异性抗原密度与良性系统前列腺活检结果后前列腺癌死亡率的关系

评估前列腺特异性抗原（PSA）密度（PSAD）与经直肠超声（TRUS）引导前列腺活检良性结果后前列腺癌死亡率之间的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.